EDITORIALS

Precision and Combination Strategies for Immune Checkpoint Inhibitors in Prostate Cancer

  • Sayegh, Nicolas MD2
  • Ozay, Zeynep Irem MD1
  • Zhang, Tian MD, MHS2,
  • Agarwal, Neeraj MD1,,

  • 1

    Division of Medical Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT

  • 2

    Division of Hematology and Oncology, Department of Internal Medicine, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
Neeraj Agarwal, MD, FASCO; e-mail: [email protected].
Journal of Clinical Oncology 43(28):p 3057-3060, October 1, 2025. | DOI: 10.1200/JCO-25-01009

Corresponding Article

Nivolumab and Ipilimumab for Metastatic Castration-Resistant Prostate Cancer With an Immunogenic Signature: The Multicenter, Two-Cohort, Phase II NEPTUNES Study

  • Leone, Gianmarco MD1
  • Wong, Yien Ning Sophia MD, PhD2,
  • Jones, Robert J. MD, PhD3,
  • Sankey, Peter MD4,
  • Josephs, Debra H. MD, PhD5,
  • Crabb, Simon J. MD, PhD6,
  • Harris, Louise MD7
  • Zarkar, Anjali MD8,
  • Protheroe, Andrew MD9,
  • Vasudev, Naveen MD, PhD10,
  • Rashid, Memuna MSc11
  • Lopes, Andre PhD11
  • Tasnim, Aniqa MSc11
  • Ensell, Leah BSc1
  • Hartley, John MD, PhD1,
  • Jayaram, Anuradha MD, PhD1
  • Kularatne, Bihani MD, PhD1,
  • Kayani, Mahaz MD1
  • Pritchard, Colin C. PhD12,
  • Konnick, Eric Q. MD12,
  • Freeman, Alex MD13
  • Haider, Aiman MD13
  • Linares, Josep BSc13
  • Attard, Gerhardt MD, PhD1,
  • Quezada, Sergio A. PhD1,
  • Swanton, Charles PhD1,
  • Marafioti, Teresa MD13
  • Linch, Mark D. MD, PhD1,,
Journal of Clinical Oncology 43(28):p 3070-3080, October 1, 2025. | DOI: 10.1200/JCO-24-02637
Copyright © 2025 by American Society of Clinical Oncology